"Hydrolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of cleaving a chemical compound by the addition of a molecule of water.
| Descriptor ID |
D006868
|
| MeSH Number(s) |
G02.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydrolysis".
Below are MeSH descriptors whose meaning is more specific than "Hydrolysis".
This graph shows the total number of publications written about "Hydrolysis" by people in this website by year, and whether "Hydrolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 7 | 7 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 8 | 8 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 6 | 6 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydrolysis" by people in Profiles.
-
Sun Z, Su L, Cotroneo N, Critchley I, Pucci M, Jain A, Palzkill T. Evaluation of Tebipenem Hydrolysis by ?-Lactamases Prevalent in Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2022 05 17; 66(5):e0239621.
-
Cui Z, Li X, Shin J, Gamper H, Hou YM, Sacchettini JC, Zhang J. Interplay between an ATP-binding cassette F protein and the ribosome from Mycobacterium tuberculosis. Nat Commun. 2022 01 21; 13(1):432.
-
Gautheron J, Morisseau C, Chung WK, Zammouri J, Auclair M, Baujat G, Capel E, Moulin C, Wang Y, Yang J, Hammock BD, Cerame B, Phan F, F?ve B, Vigouroux C, Andreelli F, Jeru I. EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence. Elife. 2021 08 03; 10.
-
Gamper H, Li H, Masuda I, Miklos Robkis D, Christian T, Conn AB, Blaha G, Petersson EJ, Gonzalez RL, Hou YM. Insights into genome recoding from the mechanism of a classic +1-frameshifting tRNA. Nat Commun. 2021 01 12; 12(1):328.
-
Presley BC, Castaneto MS, Logan BK, Jansen-Varnum SA. Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS. Biomed Chromatogr. 2020 Sep; 34(9):e4884.
-
Presley BC, Logan BK, Jansen-Varnum SA. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3). J Anal Toxicol. 2020 Apr 30; 44(3):226-236.
-
Presley BC, Logan BK, Jansen-Varnum SA. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry. Drug Test Anal. 2019 Aug; 11(8):1264-1276.
-
Wu H, LeValley PJ, Luo T, Kloxin AM, Kiick KL. Manipulation of Glutathione-Mediated Degradation of Thiol-Maleimide Conjugates. Bioconjug Chem. 2018 11 21; 29(11):3595-3605.
-
Carlier J, Diao X, Huestis MA. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection. J Pharm Biomed Anal. 2018 Aug 05; 157:27-35.
-
Sempio C, Scheidweiler KB, Barnes AJ, Huestis MA. Optimization of recombinant ?-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug Test Anal. 2018 Mar; 10(3):518-529.